Literature DB >> 3192618

Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells.

K Sawada1, S B Krantz, S T Sawyer, C I Civin.   

Abstract

Highly purified human erythroid colony-forming cells (ECFC), which consist predominately of colony-forming units-erythroid (CFU-E), were prepared from human blood and used to study the binding and processing of erythropoietin (Ep). When radioiodinated human recombinant Ep (125I-rEp) was incubated with these cells, binding was specific and saturable. Specific binding was directly proportional to cell concentration and did not occur with other human cells. Saturation of specific binding at 3 degrees C occurred at 1 nM (3.9/U/ml), and Scatchard analysis revealed two classes of binding sites on the cell surface. Of a total of 1,050 binding sites per ECFC, one-fifth had a Kd of 0.10 nM, while the remainder had a Kd of 0.57 nM. Specific binding was twofold greater at 37 degrees C than at 3 degrees C, and removal of surface-bound Ep with acid indicated that 125I-rEp was internalized into the cells after incubation at 37 degrees C. Further incubation at this temperature showed a decline of cellular radioactivity, with a release of small molecular weight degradation fragments into the medium. These studies demonstrate two classes of receptors for Ep on normal human ECFC. Internalization and degradation of EP occur, and the biologic effect of the hormone is produced by a small number of Ep molecules, as demonstrated in murine erythroid progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192618     DOI: 10.1002/jcp.1041370218

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.

Authors:  Xiaoyu Yan; Philip J Lowe; Martin Fink; Alexander Berghout; Sigrid Balser; Wojciech Krzyzanski
Journal:  J Clin Pharmacol       Date:  2011-12-12       Impact factor: 3.126

Review 2.  Erythropoietin receptor. Subunit structure and activation.

Authors:  A D D'Andrea; L I Zon
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  Erythropoietin receptors in polycythemia vera.

Authors:  R T Means; S B Krantz; S T Sawyer; H S Gilbert
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Pharmacokinetics of epoetin (recombinant human erythropoietin) after long term therapy in patients undergoing haemodialysis and haemofiltration.

Authors:  U Gladziwa; U Klotz; K Bäumer; R Zollinger; H Mann; H G Sieberth
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

5.  Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system.

Authors:  A Malek; R Sager; K U Eckardt; C Bauer; H Schneider
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

6.  Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo.

Authors:  M A Goldsmith; A Mikami; Y You; K D Liu; L Thomas; P Pharr; G D Longmore
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

7.  Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.

Authors:  P N Pharr; D Hankins; A Hofbauer; H F Lodish; G D Longmore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3.

Authors:  C H Dai; S B Krantz; R T Means; S T Horn; H S Gilbert
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

Review 9.  The erythropoietin receptor: its role in hematopoiesis and myeloproliferative diseases.

Authors:  G D Longmore; S S Watowich; D J Hilton; H F Lodish
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

10.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.